These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 922748)

  • 1. Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients.
    Klastersky J; Debusscher L; Weerts-Ruhl D; Prevost JM
    Cancer Treat Rep; 1977 Nov; 61(8):1433-9. PubMed ID: 922748
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin.
    Halpern J; Catane R; Sacks T; Fuks Z
    J Med; 1983; 14(3):193-202. PubMed ID: 6580369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
    Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 5. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of antimicrobial schemes in episodes of fever and granulocytopenia in children with cancer].
    Petrilli AS; Bianchi A; Melaragno R; de Camargo B; Kusano E; da Silva Mendonca J; Naspitz CK
    Bol Med Hosp Infant Mex; 1989 Dec; 46(12):761-6. PubMed ID: 2627271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical therapy in febrile granulocytopenic patients.
    Gaya H
    Eur J Cancer (1965); 1979; 15 Suppl():51-8. PubMed ID: 397061
    [No Abstract]   [Full Text] [Related]  

  • 8. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
    Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
    Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sulbenicillin and amikacin for febrile patients with cancer--with special reference to granulocytopenia].
    Sampi K; Honda T; Hattori M
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2377-81. PubMed ID: 6639099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients.
    Bodey GP; Valdivieso M; Feld R; Rodriguez V; McCredie K
    Am J Med Sci; 1977; 273(3):309-18. PubMed ID: 326048
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
    Cortelezzi A; Radaelli F; Penagini R; Pogliani EM
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):520-3. PubMed ID: 6983502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
    Menichetti F; Bucaneve G; Patoia L; Guerciolini R; Minotti V; Pauluzzi S; Del Favero A
    Chemioterapia; 1987 Jun; 6(2 Suppl):403-5. PubMed ID: 3334584
    [No Abstract]   [Full Text] [Related]  

  • 16. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
    J Clin Oncol; 1983 Oct; 1(10):597-603. PubMed ID: 6366126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.